U.S., China Continue to Dominate Cell Therapy Market

BEIJING--July 2, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--The U.S. and China continue to dominate the cell therapy market, with 791 and 695 related drugs in each region. From 2020 to 2021, the cumulative number of cell therapies developed in the U.S. and China increased 31% and 40%, respectively, while during 2019-2020, the number increased 40% and 69%, respectively.